| Literature DB >> 32235620 |
Soojin Park1, Songwon Seo1, Dalnim Lee1, Sunhoo Park1, Young Woo Jin1.
Abstract
The Korean Radiation Worker Study investigated the health effects of protracted low-dose radiation among nuclear-related occupations in the Nuclear Safety and Security Commission in Korea. From 2016-2017, 20,608 workers were enrolled (86.5% men and 30.7% nuclear power plant workers). The mean cumulative dose ± standard deviation between 1984 and 2017 (1st quarter) was 11.8 ± 28.8 (range 0-417) mSv. Doses below recording level (≤0.1 mSv) were reported in 7901 (38.3%) cases; 431 (2%) had cumulative doses ≥100 mSv. From 1999-2016, 212 cancers (189 men, 23 women) occurred; thyroid cancer predominated (39.2%, 72 men, 11 women). In men, the standardized incidence ratio (SIR) for all cancers was significantly decreased (SIR = 0.76, 95% CI 0.66-0.88); however, that for thyroid cancer was significantly increased (SIR = 1.94, 95% CI 1.54-2.44). Compared to the non-exposed group (≤0.1 mSv), the relative risk (RR) in the exposed group (>0.1 mSv) after adjusting for sex, attained age, smoking status, and duration of employment was 0.82 (95% CI 0.60-1.12) for all cancers and 0.83 (95% CI 0.49-1.83) for thyroid cancer. The preliminary findings from this baseline study with a shorter follow-up than the latency period for solid cancer cannot exclude possible associations between radiation doses and cancer risk.Entities:
Keywords: epidemiology; neoplasm; occupational exposure; radiation
Year: 2020 PMID: 32235620 PMCID: PMC7177891 DOI: 10.3390/ijerph17072328
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Enrollment of the study population.
Demographic characteristics of the cohort (N = 20,608).
| Characteristics | n | (%) |
|---|---|---|
| Sex | ||
| Men | 17,831 | (86.5%) |
| Women | 2777 | (13.5%) |
| Birth year | ||
| ~1960 | 1391 | (6.7%) |
| 1961–1970 | 3449 | (16.7%) |
| 1971–1980 | 5891 | (28.6%) |
| 1981~ | 9877 | (47.9%) |
| Education level | ||
| Less than high school graduation | 159 | (0.8%) |
| High school graduation | 4539 | (22.6%) |
| College graduation and above | 15,402 | (76.6%) |
| Marital status | ||
| Unmarried | 7881 | (39.2%) |
| Married/living together | 11,982 | (59.6%) |
| Other (divorced, widow, separated) | 233 | (1.2%) |
| BMI, kg/m2 | ||
| Underweight (<18.5) | 490 | (2.6%) |
| Normal weight (18.5–24.9) | 11,677 | (61.2%) |
| Overweight (25.0–29.9) | 6012 | (31.5%) |
| Obese (≥30.0) | 913 | (4.8%) |
| Regular exercise | ||
| No | 9061 | (44.3%) |
| Yes | 11,385 | (55.7%) |
| Smoking status | ||
| Never (non-smoker) | 8442 | (41.3%) |
| Ex-smoker | 3615 | (17.7%) |
| Yes (smoker) | 8361 | (40.9%) |
| Alcohol status | ||
| No | 3276 | (16.0%) |
| Yes | 17,239 | (84.0%) |
BMI, body mass index.
Occupational characteristics of the cohort (N = 20,608).
| Characteristics | n | (%) |
|---|---|---|
| Occupation | ||
| Public institute | 676 | (3.3%) |
| Education institute | 2010 | (9.8%) |
| Military | 165 | (0.8%) |
| Industrial radiography | 3517 | (17.1%) |
| Industry | 3886 | (18.9%) |
| Research institute | 1139 | (5.5%) |
| Nuclear power plant | 6328 | (30.7%) |
| Medical institute | 2887 | (14.0%) |
| Calendar year of hiring | ||
| ~1989 | 1272 | (6.2%) |
| 1990–1999 | 2694 | (13.1%) |
| 2000–2009 | 4569 | (22.2%) |
| 2010~ | 12,073 | (58.6%) |
| Age at the start of radiation work, years | ||
| <20 | 785 | (3.8%) |
| 20–29 | 12,168 | (59.0%) |
| 30–39 | 5449 | (26.4%) |
| 40–49 | 1565 | (7.6%) |
| ≥50 | 641 | (3.1%) |
| Employment status | ||
| Regular employment | 16,450 | (82.6%) |
| Irregular employment (temporary contract) | 2885 | (14.5%) |
| Irregular employment (daily contract) | 589 | (3.0%) |
| Duration of employment, years | ||
| ≤4 | 9265 | (45.0%) |
| 5–9 | 4310 | (20.9%) |
| 10–14 | 2372 | (11.5%) |
| ≥15 years | 4661 | (22.6%) |
| Experience of warning for exceeding 5 mSv per quarter | ||
| No | 17,857 | (90.4%) |
| Yes | 901 | (4.6%) |
| I do not know | 987 | (5.0%) |
| Night shifts | ||
| None | 10,361 | (51.1%) |
| <1 year | 2544 | (12.5%) |
| 1–5 years | 4215 | (20.8%) |
| >5 years | 3152 | (15.5%) |
| Radiation source | ||
| None | 2873 | (14.6%) |
| Sealed isotope | 5309 | (26.9%) |
| Unsealed isotope | 2430 | (12.3%) |
| Radiation-generating device | 5559 | (28.2%) |
| Not sure | 3539 | (18.0%) |
| Distance from radiation source | ||
| <1 m | 3752 | (20.0%) |
| 1–3 m | 4866 | (25.9%) |
| >3 m | 10,149 | (54.1%) |
| While engaged in radiation work, white blood cell counts fell below the normal range | ||
| No | 17,922 | (90.5%) |
| Yes | 498 | (2.5%) |
| Not sure (or had never had a health examination) | 1381 | (7.0%) |
Distribution of radiation doses (Hp(10)) and the number of workers receiving doses >20 mSv per year, 1984–2017.
| Report Year | No. of Workers | Annual Collective Dose (man.mSv) | Annual Radiation Dose (mSv [mean ± SD]) | No. of Workers >20 mSv Per Year (%) | |
|---|---|---|---|---|---|
| 1984 | 417 | 1876.55 | 4.5 ± 6.9 | 25 | (6.0) |
| 1985 | 563 | 1831.57 | 3.2 ± 5.5 | 14 | (2.5) |
| 1986 | 683 | 3150.87 | 4.6 ± 7.5 | 46 | (6.7) |
| 1987 | 870 | 2923.13 | 3.4 ± 5.8 | 25 | (2.9) |
| 1988 | 1085 | 4210.68 | 3.9 ± 7.2 | 64 | (5.9) |
| 1989 | 1213 | 3428.80 | 2.8 ± 4.9 | 20 | (1.6) |
| 1990 | 1348 | 4567.53 | 3.4 ± 6.0 | 42 | (3.1) |
| 1991 | 1491 | 3494.45 | 2.3 ± 4.4 | 21 | (1.4) |
| 1992 | 1690 | 4145.30 | 2.5 ± 4.4 | 19 | (1.1) |
| 1993 | 1763 | 4557.83 | 2.6 ± 4.7 | 24 | (1.4) |
| 1994 | 2041 | 4554.59 | 2.2 ± 4.2 | 18 | (0.9) |
| 1995 | 2457 | 6528.34 | 2.7 ± 5.1 | 47 | (1.9) |
| 1996 | 2725 | 6803.13 | 2.5 ± 4.5 | 32 | (1.2) |
| 1997 | 2890 | 5958.99 | 2.1 ± 3.8 | 14 | (0.5) |
| 1998 | 3140 | 6199.69 | 2.0 ± 3.6 | 7 | (0.2) |
| 1999 | 3502 | 6887.96 | 2.0 ± 3.3 | 6 | (0.2) |
| 2000 | 3696 | 7041.37 | 1.9 ± 3.4 | 14 | (0.4) |
| 2001 | 4008 | 7156.33 | 1.8 ± 3.4 | 9 | (0.2) |
| 2002 | 4212 | 6922.35 | 1.6 ± 2.9 | 10 | (0.2) |
| 2003 | 4463 | 6950.28 | 1.6 ± 2.8 | 8 | (0.2) |
| 2004 | 4925 | 8413.59 | 1.7 ± 3.3 | 15 | (0.3) |
| 2005 | 5302 | 8732.94 | 1.6 ± 3.1 | 17 | (0.3) |
| 2006 | 5812 | 9113.73 | 1.6 ± 2.9 | 14 | (0.2) |
| 2007 | 6447 | 10,275.9 | 1.6 ± 2.9 | 10 | (0.2) |
| 2008 | 6986 | 9385.69 | 1.3 ± 3.2 | 31 | (0.4) |
| 2009 | 7605 | 9844.92 | 1.3 ± 3.1 | 27 | (0.4) |
| 2010 | 8350 | 11,133.14 | 1.3 ± 3.3 | 46 | (0.6) |
| 2011 | 9440 | 10,743.07 | 1.1 ± 2.8 | 30 | (0.3) |
| 2012 | 10,803 | 13,282.39 | 1.2 ± 3.4 | 50 | (0.5) |
| 2013 | 11,965 | 15,290.65 | 1.3 ± 3.5 | 72 | (0.6) |
| 2014 | 13,419 | 11,881.34 | 0.9 ± 2.4 | 18 | (0.1) |
| 2015 | 15,568 | 10,974.39 | 0.7 ± 2.2 | 17 | (0.1) |
| 2016 | 18,861 | 11,352.00 | 0.6 ± 1.9 | 15 | (0.1) |
| 2017 | 18,411 | 2844.70 | 0.2 ± 0.7 | 3 | (0.0) |
| Total | 20,608 | 242,198.04 | 1.3 ± 3.2 | 602 | (2.9) |
Radiation doses until the 1st quarter of 2017. SD, standard deviation.
Figure 2Annual average radiation dose (Hp(10)) by occupation types.
Figure 3Distribution of cumulative dose in the cohort (1984–the 1st quarter of 2017).
Number of observed cases, SIR, and 95% CI among radiation workers in South Korea.
| Cancer/Site | Men (n = 16,943) | Women (n = 2584) | ||||
|---|---|---|---|---|---|---|
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | |||
| All cancers combined (C00–C96) | 189 | 0.76 | (0.66–0.88) | 23 | 0.84 | (0.56–1.26) |
| Oral cavity (C03–C06) | 1 | 1.15 | (0.16–8.13) | 0 | 0 | (0–99.86) |
| Salivary gland (C07–C08) | 3 | 2.98 | (0.96–9.25) | 0 | 0 | (0–42.80) |
| Stomach (C16) | 44 | 0.95 | (0.70–1.27) | 1 | 0.63 | (0.09–4.45) |
| Small intestine (C17) | 1 | 0.84 | (0.12–5.94) | 0 | 0 | (0–74.90) |
| Colon (C18) | 15 | 0.93 | (0.56–1.54) | 0 | 0 | (0–4.68) |
| Rectum (C19) | 10 | 0.56 | (0.30–1.04) | 0 | 0 | (0–5.08) |
| Liver (C22) | 7 | 0.20 | (0.10–0.43) | 0 | 0 | (0–8.81) |
| Nose, sinuses, etc. (C30–C31) | 2 | 2.98 | (0.74–11.91) | 0 | 0 | (0–99.86) |
| Lung (C33–C34) | 4 | 0.23 | (0.09–0.61) | 0 | 0 | (0–5.76) |
| Bone (C40–C41) | 1 | 0.89 | (0.13–6.31) | 0 | 0 | (0–33.29) |
| Melanoma of skin (C43) | 1 | 1.41 | (0.20–9.98) | 0 | 0 | (0–74.90) |
| Other skin (C44) | 1 | 0.30 | (0.04–2.11) | 0 | 0 | (0–18.72) |
| Breast (C50) | 0 | 0 | (0–14.97) | 9 | 1.51 | (0.79–2.90) |
| Cervix uteri (C53) | - | - | - | 1 | 0.65 | (0.09–4.60) |
| Uterus, part unspecified (C55) | - | - | - | 1 | 25.86 | (3.64–183.60) |
| Prostate (C61) | 5 | 0.88 | (0.37–2.12) | - | - | - |
| Testis (C62) | 2 | 0.98 | (0.24–3.91) | - | - | - |
| Kidney (C64) | 10 | 1.07 | (0.57–1.98) | 0 | 0 | (0–13.02) |
| Bladder (C67) | 2 | 0.46 | (0.11–1.82) | 0 | 0 | (0–59.91) |
| Brain, nervous system (C70–C72) | 1 | 0.25 | (0.04–1.79) | 0 | 0 | (0–11.98) |
| Thyroid (C73) | 72 | 1.94 | (1.54–2.44) | 11 | 0.92 | (0.51–1.66) |
| Adrenal grand (C74) | 1 | 4.29 | (0.60–30.43) | 0 | 0 | (0–149.79) |
| Hodgkin lymphoma (C81) | 1 | 1.36 | (0.19–9.66) | 0 | 0 | (0–42.80) |
| Non-Hodgkin lymphoma (C82–C86) | 2 | 0.28 | (0.07–1.13) | 0 | 0 | (0–8.32) |
| Multiple myeloma (C90) | 1 | 0.86 | (0.12–6.10) | 0 | 0 | (0–74.90) |
| Leukemia (C91–C95) | 2 | 0.33 | (0.08–1.32) | 0 | 0 | (0–7.88) |
Obs, observed; SIR, standardized incidence ratio; CI, confidence interval.
The SIR and 95% CI for all cancers, thyroid cancer, and all cancers excluding thyroid cancer stratified by occupation and birth year.
| Characteristics | n | All Cancers Combined | All Cancers Combined Excluding Thyroid Cancer | Thyroid Cancer | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | Obs | SIR (95% CI) | |||||
|
| ||||||||||
| Public institute | 644 | 10 | 1.03 | (0.55–1.91) | 8 | 0.98 | (0.49–1.96) | 2 | 1.29 | (0.32–5.14) |
| Education institute | 1805 | 10 | 0.70 | (0.38–1.30) | 8 | 0.77 | (0.38–1.53) | 2 | 0.51 | (0.13–2.05) |
| Military | 164 | 2 | 2.25 | (0.56–8.99) | 0 | 0 | (0–4.68) | 2 | 8.26 | (2.07–33.04) |
| Industrial radiography | 3415 | 12 | 0.36 | (0.20–0.63) | 10 | 0.38 | (0.20–0.70) | 2 | 0.28 | (0.07–1.13) |
| Industry | 3645 | 42 | 0.96 | (0.71–1.30) | 26 | 0.75 | (0.49–1.05) | 16 | 2.15 | (1.32–3.50) |
| Research institute | 1071 | 17 | 0.63 | (0.39–1.02) | 11 | 0.47 | (0.26–0.85) | 6 | 1.75 | (0.78–3.89) |
| Nuclear power plant | 6037 | 93 | 0.88 | (0.72–1.08) | 53 | 0.59 | (0.45–0.77) | 40 | 2.68 | (1.97–3.65) |
| Medical institute | 2746 | 26 | 0.63 | (0.43–0.93) | 13 | 0.43 | (0.25–0.73) | 13 | 1.23 | (0.72–2.12) |
|
| ||||||||||
| ~1950 | 103 | 8 | 0.45 | (0.23–0.91) | 8 | 0.46 | (0.23–0.93) | 0 | 0 | (0–8.32) |
| 1951–1960 | 1241 | 52 | 0.62 | (0.47–0.81) | 41 | 0.52 | (0.39–0.71) | 11 | 2.01 | (1.11–3.63) |
| 1961–1970 | 3350 | 71 | 0.76 | (0.60–0.96) | 49 | 0.62 | (0.47–0.83) | 22 | 1.46 | (0.96–2.22) |
| 1971–1980 | 5719 | 61 | 1.04 | (0.81–1.34) | 23 | 0.58 | (0.39–0.88) | 38 | 1.97 | (1.44–2.71) |
| 1981–1990 | 7314 | 18 | 0.88 | (0.55–1.40) | 7 | 0.59 | (0.28–1.24) | 11 | 1.27 | (0.71–2.30) |
| 1991~ | 1800 | 2 | 1.85 | (0.46–7.40) | 1 | 1.43 | (0.20–10.17) | 1 | 2.61 | (0.37–18.56) |
Obs, observed; SIR, standardized incidence ratio; CI, confidence interval.
Relative risks of cancer between the exposed and non-exposed groups (≤0.1 mSv).
| Cancer | Exposed Workers (n = 12,065) | Non-Exposed Workers (n = 7462) | Crude RR (95% CI) | Adj† RR (95% CI) | ||||
|---|---|---|---|---|---|---|---|---|
| Obs | SIR (95% CI) | Obs | SIR (95% CI) | |||||
| All cancers combined | 151 | 0.69 | (0.59–0.81) | 61 | 1.05 | (0.82–1.36) | 0.64 | 0.82 |
| All cancers combined excluding thyroid cancer | 92 | 0.51 | (0.42–0.63) | 37 | 0.79 | (0.58–1.10) | 0.64 | 0.83 |
| Thyroid cancer | 59 | 1.55 | (1.20–2.00) | 24 | 2.17 | (1.46–3.24) | 0.63 | 0.83 |
† Adjusted by sex, attained age, birth year, smoke status and duration of employment. Obs, observed; SIR, standardized incidence ratio; CI, confidence interval; Adj, adjusted; RR, relative risk.